BrainStorm Cell Therapeutics to Provide Corporate Update at the BIO International Convention

BrainStorm Cell Therapeutics to Provide Corporate Update at the BIO International Convention

NEW YORK and PETACH TIKVAH, Israel, May 30, 2018 /PRNewswire/ — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that the Company will present a corporate overview at the BIO International Convention, taking place June